These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9529283)

  • 1. Combined thallium-201 myocardial with technetium-99m-HMPAO brain SPECT: myocardial ischemia induced by acetazolamide in severe coronary artery disease.
    Shimotsu Y; Hayashida K; Hirose Y; Kume N; Nishimura T
    J Nucl Med; 1998 Mar; 39(3):408-10. PubMed ID: 9529283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetazolamide induced myocardial ischemia in patients with severe coronary artery disease.
    Shimotsu Y; Hayashida K; Kume N; Fukuchi K; Nishimura T
    Ann Nucl Med; 1998 Feb; 12(1):21-7. PubMed ID: 9559958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT.
    Burt RW; Witt RM; Cikrit DF; Reddy RV
    Radiology; 1992 Feb; 182(2):461-6. PubMed ID: 1732965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with
    Acker G; Lange C; Schatka I; Pfeifer A; Czabanka MA; Vajkoczy P; Buchert R
    J Nucl Med; 2018 Feb; 59(2):294-298. PubMed ID: 28729429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perfusion SPECT with (99m)Tc-HMPAO in type I diabetics with no background of central neurologic symptoms. A study of activation with acetazolamide].
    Jiménez-Bonilla J; Carril JM; Quirce R; Amado JA; Hernández A; Vallina NK; Uriarte I; Montero A
    Rev Esp Med Nucl; 2000 Jun; 19(3):187-91. PubMed ID: 11062081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
    Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
    Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
    Burt RW; Witt RM; Cikrit D; Carter J
    Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
    Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
    Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB
    Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease.
    Hwang TL; Saenz A; Farrell JJ; Brannon WL
    J Nucl Med; 1996 Oct; 37(10):1595-9. PubMed ID: 8862290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.
    Berman DS; Hachamovitch R; Kiat H; Cohen I; Cabico JA; Wang FP; Friedman JD; Germano G; Van Train K; Diamond GA
    J Am Coll Cardiol; 1995 Sep; 26(3):639-47. PubMed ID: 7642853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of coronary artery bypass surgery on brain perfusion.
    Degirmenci B; Durak H; Hazan E; Karabay O; Derebek E; Yilmaz M; Ozbilek E; Oto O
    J Nucl Med; 1998 Apr; 39(4):587-91. PubMed ID: 9544661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar vasoreactivity in stroke patients with crossed cerebellar diaschisis assessed by acetazolamide and 99mTc-HMPAO SPECT.
    Kim SE; Lee MC
    J Nucl Med; 2000 Mar; 41(3):416-20. PubMed ID: 10716312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
    Murakami M; Yonehara T; Takaki A; Fujioka S; Hirano T; Ushio Y
    J Nucl Med; 2002 May; 43(5):577-83. PubMed ID: 11994517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-day protocol for cerebral perfusion reserve with acetazolamide.
    Hattori N; Yonekura Y; Tanaka F; Fujita T; Wang J; Ishizu K; Okazawa H; Tamaki N; Konishi J
    J Nucl Med; 1996 Dec; 37(12):2057-61. PubMed ID: 8970534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-HMPAO brain SPECT in neonates with hypoglycemic encephalopathy.
    Chiu NT; Huang CC; Chang YC; Lin CH; Yao WJ; Yu CY
    J Nucl Med; 1998 Oct; 39(10):1711-3. PubMed ID: 9776274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.
    Devous MD; Payne JK; Lowe JL
    J Nucl Med; 1992 Nov; 33(11):1919-24. PubMed ID: 1432149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon dioxide reactivity by consecutive technetium-99m-HMPAO SPECT in patients with a chronically obstructed major cerebral artery.
    Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Okazaki Y; Seike Y; Handa N; Uehara T; Kamada T; Nishimura T
    J Nucl Med; 1994 Jan; 35(1):32-40. PubMed ID: 8271057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.